STAT3 gain of function: genes and variants
Explore variant evidence for STAT3 gain of function across 1 analyzed protein (STAT3). Linked ClinVar records include 49 pathogenic or likely pathogenic variants, 141 variants of uncertain significance and 26 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to STAT3 gain of function
STAT3: Signal transducer and activator of transcription 3
It translates cytokine and growth-factor signals into transcriptional programs governing immune regulation, survival, proliferation, and tissue repair. Dominant-negative variants cause hyper-IgE syndrome, while activating germline variants cause early autoimmunity and lymphoproliferation and somatic activation contributes to cancer.
49 ClinVar pathogenic / likely pathogenic and 167 uncertain variants in STAT3 have source records linked to STAT3 gain of function. Association strength is not clinical gene validity.
Where STAT3 gain of function variants cluster
- STAT3 SH2 (positions 580–670): 16 of 45 ClinVar pathogenic / likely pathogenic variants, 3.0× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to STAT3 gain of function
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| STAT3 R382W | 382 | Pathogenic / likely pathogenic (★★) | |
| STAT3 R382Q | 382 | Pathogenic / likely pathogenic (★★) | |
| STAT3 F621L | 621 | SH2 | Pathogenic / likely pathogenic (★★) |
| STAT3 V637M | 637 | SH2 | Pathogenic / likely pathogenic (★★) |
| STAT3 L706P | 706 | Pathogenic / likely pathogenic (★★) | |
| STAT3 R278C | 278 | Pathogenic / likely pathogenic (★★) | |
| STAT3 G421R | 421 | Pathogenic / likely pathogenic (★★) | |
| STAT3 R423Q | 423 | Pathogenic / likely pathogenic (★★) | |
| STAT3 Y657C | 657 | SH2 | Pathogenic / likely pathogenic (★★) |
| STAT3 I659N | 659 | SH2 | Pathogenic / likely pathogenic (★★) |
| STAT3 M660T | 660 | SH2 | Pathogenic / likely pathogenic (★★) |
| STAT3 K709E | 709 | Pathogenic / likely pathogenic (★★) | |
| STAT3 P715L | 715 | Pathogenic / likely pathogenic (★★) | |
| STAT3 R152W | 152 | Essential for nuclear import | Pathogenic / likely pathogenic (★★) |
| STAT3 H332Y | 332 | Pathogenic / likely pathogenic (★★) | |
| STAT3 R335W | 335 | Pathogenic / likely pathogenic (★★) | |
| STAT3 T389A | 389 | Pathogenic / likely pathogenic (★★) | |
| STAT3 N466T | 466 | Pathogenic / likely pathogenic (★★) | |
| STAT3 E594K | 594 | SH2 | Pathogenic / likely pathogenic (★★) |
| STAT3 L673P | 673 | Pathogenic / likely pathogenic (★★) | |
| STAT3 T716M | 716 | Pathogenic / likely pathogenic (★★) | |
| STAT3 P695L | 695 | Pathogenic / likely pathogenic (★★) | |
| STAT3 R382P | 382 | Pathogenic / likely pathogenic (★) | |
| STAT3 F621V | 621 | SH2 | Pathogenic / likely pathogenic (★) |
| STAT3 S636F | 636 | SH2 | Pathogenic / likely pathogenic (★) |
| STAT3 S636Y | 636 | SH2 | Pathogenic / likely pathogenic (★) |
| STAT3 V637L | 637 | SH2 | Pathogenic / likely pathogenic (★) |
| STAT3 P639A | 639 | SH2 | Pathogenic / likely pathogenic (★) |
| STAT3 P639T | 639 | SH2 | Pathogenic / likely pathogenic (★) |
| STAT3 Y705C | 705 | Pathogenic / likely pathogenic (★) | |
| STAT3 Y705H | 705 | Pathogenic / likely pathogenic (★) | |
| STAT3 T714I | 714 | Pathogenic / likely pathogenic (★) | |
| STAT3 T714K | 714 | Pathogenic / likely pathogenic (★) | |
| STAT3 L706M | 706 | Pathogenic / likely pathogenic (★) | |
| STAT3 R278H | 278 | Pathogenic / likely pathogenic (★) | |
| STAT3 M394T | 394 | Pathogenic / likely pathogenic (★) | |
| STAT3 M394I | 394 | Pathogenic / likely pathogenic (★) | |
| STAT3 T620S | 620 | SH2 | Pathogenic / likely pathogenic (★) |
| STAT3 T622I | 622 | SH2 | Pathogenic / likely pathogenic (★) |
| STAT3 K642E | 642 | SH2 | Pathogenic / likely pathogenic (★) |
| STAT3 Y672C | 672 | Pathogenic / likely pathogenic (★) | |
| STAT3 V713L | 713 | Pathogenic / likely pathogenic (★) | |
| STAT3 R103W | 103 | Pathogenic / likely pathogenic (★) | |
| STAT3 L287F | 287 | Pathogenic / likely pathogenic (★) | |
| STAT3 M329K | 329 | Pathogenic / likely pathogenic (★) | |
| STAT3 H410Y | 410 | Pathogenic / likely pathogenic (★) | |
| STAT3 H437Q | 437 | Pathogenic / likely pathogenic (★) | |
| STAT3 T600S | 600 | SH2 | Pathogenic / likely pathogenic (★) |
| STAT3 L645Q | 645 | SH2 | Pathogenic / likely pathogenic (★) |
Uncertain variants prioritized for review in STAT3 gain of function
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| STAT3 R335Q | 335 | Conflicting reports (★) | +7: 2 other pathogenic changes within 3 positions; R335W at the same position is pathogenic; seen in 4.1e-06 of gnomAD DNA copies; REVEL 0.818 | |
| STAT3 G421E | 421 | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; G421R at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.700 |
Which prediction tools work for STAT3 gain of function
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- AlphaMissense: 92 out of 100
- ESM1b (LLR): 89 out of 100
- CADD: 88 out of 100
- REVEL: 88 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 87 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 85 out of 100
- MutPred: 82 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 81 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 81 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 79 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- phyloP: 56 out of 100
- SpliceAI: 47 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Hyper-IgE recurrent infection syndrome also has ClinVar records linked to STAT3 variants; they fall in the same places as the STAT3 gain of function variants (65 pathogenic / likely pathogenic).
- STAT3-related early-onset multisystem autoimmune disease also has ClinVar records linked to STAT3 variants; they fall partly in the same places as the STAT3 gain of function variants (21 pathogenic / likely pathogenic).
Diseases related to STAT3 gain of function
- Hyper-IgE recurrent infection syndrome, also linked to STAT3
- STAT3-related early-onset multisystem autoimmune disease, also linked to STAT3
- Inherited Immunodeficiency Diseases, also linked to STAT3
- Crohn disease, also linked to STAT3
- Hyper-IgE syndrome 6, autosomal dominant, with recurrent infections, also linked to STAT3
Frequently asked questions
Which genes have records linked to STAT3 gain of function?
This view contains 1 analyzed proteins: STAT3. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 49 pathogenic or likely pathogenic variants, 141 variants of uncertain significance and 26 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 2 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 246 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center